190 related articles for article (PubMed ID: 34003542)
1. Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
Duffell E; Cortez-Pinto H; Simonova M; Dalgard O; Dahl EH; de Martel C; Mozalevskis A; Buti M; Pavlova S; Hadzhilova T; Simões C; Katzarov K; Mardh O
J Viral Hepat; 2021 Aug; 28(8):1177-1189. PubMed ID: 34003542
[TBL] [Abstract][Full Text] [Related]
2. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
[No Abstract] [Full Text] [Related]
3. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C and hepatitis B-related mortality in Spain.
García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
[TBL] [Abstract][Full Text] [Related]
5. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
6. Study of liver cirrhosis over ten consecutive years in Southern China.
Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
Makarova M; Krettek A; Valkov MY; Grjibovski AM
Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
9. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
[TBL] [Abstract][Full Text] [Related]
10. Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets.
Shah SHBU; Alavi M; Hajarizadeh B; Matthews G; Valerio H; Dore GJ
J Viral Hepat; 2023 Jun; 30(6):520-529. PubMed ID: 36843500
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
12. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Fattovich G; Stroffolini T; Zagni I; Donato F
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
[TBL] [Abstract][Full Text] [Related]
14. Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection.
Jiang JJ; Shiels MS; O'Brien TR
J Viral Hepat; 2021 Jun; 28(6):934-941. PubMed ID: 33720473
[TBL] [Abstract][Full Text] [Related]
15. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
Shiels MS; Engels EA; Yanik EL; McGlynn KA; Pfeiffer RM; O'Brien TR
Cancer; 2019 Aug; 125(15):2621-2630. PubMed ID: 30980394
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
17. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
Maucort-Boulch D; de Martel C; Franceschi S; Plummer M
Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206
[TBL] [Abstract][Full Text] [Related]
18. Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.
Wang H; Swann R; Thomas E; Innes HA; Valerio H; Hayes PC; Allen S; Barclay ST; Wilks D; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley AJ; Gunson R; Mclntyre PG; Hunt A; Hutchinson SJ; Mills PR; Dillon JF
J Viral Hepat; 2018 Aug; 25(8):930-938. PubMed ID: 29577515
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology and prevention of hepatocellular carcinoma.
Monto A; Wright TL
Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
